13:00 Educational session
Chengcan Yao (25 min)
“An update of PGE2’s roles in mucosal inflammation”
Cécile Gladine (25 min)
"Inter-individual variability of the circulating oxylipin profiles in humans: major determinants and consequences in clinical research"
Craig Wheelock (20 min) & John Newman (20 min)
Titles TBA
Coffee break (30 min)
15:00 1st Sponsored Session by United Therapeutics Corporation
(PGI2 analogues from bench to bedside)
Lucie Clapp (University College London, UK) (30 min)
"Multiple cellular targets for prostacyclin (IP) receptor agonists; therapeutic implications in pulmonary hypertension"
Olivier Sitbon (AP-HP, Hôpital de Bicêtre - Université Paris-Sud, France) (30 min)
"Therapeutic use of prostacyclin in pulmonary hypertension"
1 talk selected from the submitted abstracts (15 min)
1 talk selected from the submitted abstracts (15 min)
Coffee break (30 min)
17:00 2nd Sponsored Session (Resolution of Inflammation)
Charles Serhan (Brigham and Women's Hospital-Harvard Medical School, Boston, US) (40 min)
“Pro-resolving lipid mediators are novel signals for tissue regeneration"
Marc Dubourdeau (Ambiotis SAS, Toulouse, France) (30 min)
“Resolution lipid signature in different physiological and pathological contexts”
1 talk selected from the submitted abstracts (20 min)
Welcome Reception 18h30